ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Begins PLCO Screening Trial

November 26, 1993

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

House Passes Bill On New Cigarette Labels

September 14, 1984

Harold Varmus Addresses the NCI Board of Scientific Advisors

March 8, 2013

New Model Provides Better Estimate of Breast Cancer Risk in Black Women.

November 30, 2007

Erbitux Improves Survival In Advanced Colorectal Cancer

November 30, 2007